(S)-N-[(1-Ethyl-2-Pyrrolidinyl)methyl]-5-[125I]Iodo-2-Methoxy Benzamide Hydrochloride, a New Selective Radioligand for Dopamine D-2 Receptors

Journal of Medicinal Chemistry

Volumn 31, Issue 10, 1988, Pages 2027-2033

  de Paulis, Tomas ^a   Smith, Howard E ^a   Janowsky, Aaron ^b   Kessler, Robert M ^b   Clanton, Jeffrey A ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; IODINE 125; N (1 ETHYL 2 PYRROLIDINYLMETHYL)BENZAMIDE DERIVATIVE; RACLOPRIDE; RADIOISOTOPE; SULPIRIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; BLOOD BRAIN BARRIER; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; NONHUMAN; RAT;

ANIMAL; BENZAMIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ISOMERISM; KINETICS; MALE; PYRROLIDINES; RADIOLIGAND ASSAY; RATS; RATS, INBRED STRAINS; RECEPTORS, DOPAMINE;

EID: 0023721868     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00118a031     Document Type: Article

References (43)

1. Seevers, R. H.; Counsell, R. E. Chem. Rev. 1982, 82, 575-590.
2. Sedvall, G.; Farde, L.; Persson, A; Wiesel, F.-A. Arch. Gen. Psychiat. 1986, 43, 995-1005.
3. lorio, L. C.; Barnett, A.; Leitz, F. H.; Houser, V. P.; Korduba, C. A. J. Pharmacol. Exp. Ther. 1983, 226, 462-468.
4. Sidhu, A.; van Gene, J. C.; Dandridge, P.; Kaiser, C.; Kebabian, J. W. Eur. J. Pharmacol. 1986, 128, 213-220.
5. Nakatsuka, I.; Saji, H.; Shiba, K.; Shimizu, H.; Okuno, M.; Yoshitake, A.; Yokoyama, A. Life Sci. 1987, 41, 1989-1997.
6. Gundlach, A. L.; Largent, B. L.; Synder, S. H. Life Sci. 1984, 35, 1981-1988.
7. Kilpatrick, G. J.; Jenner, P.; Marsden, C. D. J. Pharm. Pharmacol. 1986, 38, 406-408.
8. Neumeyer, J. L.; Guan, J.-H.; Niznik, H. B.; Dumbrille-Ross, A.; Seeman, P.; Padmanabhan, S.; Elmaleh, D. R. J. Med. Chem. 1985, 28, 405-407.
9. de Paulis, T. In Proceedings of the VHIth International Symposium on Medicinal Chemistry; Dahlbom, R., Nilsson, J. L. G.; Eds.; Swedish Pharmaceutical: Stockholm, 1985; Vol. 1, pp 405-425.
10. Cardoso, M. T.; Pradelles, P. J. Labelled Compd. Radiopharm. 1982, 19, 1103-1109.
11. Martres, M.-P.; Sales, N.; Bouthenet, M.-L.; Schwartz, J.-C. Eur. J. Pharmacol. 1985, 118, 211-219.
12. Martres, M.-P.; Bouthenet, M.-L.; Sales, N.; Sokoloff, P.; Schwartz, J.-C. Science (Washington, D.C.) 1985,228, 752-755.
13. Martres, M.-P., Department of Neurobiology, Paul Broca Center, Paris, personal communication, 1985.
14. de Paulis, T.; Kumar, Y.; Johansson, L.; Rämsby, S.; Florvall, L.; Hall, H.; Ängeby-Möller, K.; Ögren, S.-O. J. Med. Chem. 1985, 28, 1263-1269.
15. Crawley, J. C. W.; Smith, T.; Zanelli, G. D.; Oldland, S. R. D.; Owen, F.; Veall, N. Clin. Sci. 1986, 70, Suppl 13, (Abstr. 145).
16. Kung, H. F.; Guo, Y.-Z.; Billings, J.; Xu, X.-J.; Mach, R. H.; Blau, M.; Ackerhalt, R. E. Nucl. Med. Biol. 1988,15, 195-201.
17. Zahniser, N. R.; Dubocovich, M. L. J. Pharmacol. Exp. Ther. 1983, 227, 592-599.
18. Miller, C. S.; Engelhard, E. L.; Thominet, M. L. Fr. Pat. M 5916, 1968;
19. Miller, C. S.; Engelhard, E. L.; Thominet, M. L. Chem. Abstr. 1969, 71, 70484a.
20. Andrews, C. D.; Woodruff, G. N. Br. J. Pharmacol. 1978, 64, 434P.
21. de Paulis, T.; Hall, H. In QSAR in Design of Bioactive Compounds; Kuchar, M., Ed.; Prous: Barcelona, 1984; pp 199-208.
22. Bergman, J. J.; Griffith, E. A. H.; Robertson, B. E.; Chandler, W. D. Can. J. Chem. 1973, 51, 162-170.
23. Bulteau, G. S. African Pat. 6802593, 1968;
24. Bulteau, G. S. Chem. Abstr. 1969, 71, 303546.
25. Heindel, N. D.; Van Dorf, M. J. Org. Chem. 1985, 50, 1988-1990.
26. Moerlein, S. M.; Coenen, H. H. J. Chem. Soc., Perkin Trans. 1, 1985, 1941-1947.
27. Azizian, H.; Eaborn, C.; Pidcock, A. J. Organomet. Chem. 1981, 215, 49-58.
28. Lumbroso, H.; Rumpf, P. Bull Soc. Chim. Fr. 1951, 628-632.
29. Simonsen, J. L.; Rau, M. G. J. Chem. Soc. 1917, 111, 220-236.
30. Hirwe, N. W.; Gavanker, K. D. Proc. Indian Acad. Sci. 1937, 5A, 377-380;
31. Hirwe, N. W.; Gavanker, K. D. Chem. Abstr. 1937, 31, 6216.
32. Coffen, D. L.; Schaer, B.; Bizzarro, F. T.; Cheung, J. B. J. Org. Chem. 1984, 49, 296-300.
33. Van Damme, M.; Hanocq, M.; Molle, L. Pharm. Acta Helv. 1984, 59, 235-240.
34. Craig, P. N. J. Med. Chem. 1971, 14, 680-684.
35. Mizuchi, A.; Kitagawa, N.; Miyachi, Y. Psychopharmacology 1983, 81, 195-198.
36. Imafuku, J. Brain Res. 1987, 402, 331-338.
37. Benakis, A.; Brown, J. P. H.; Benard, P. Eur. J. Drug Metab. Pharmacokin. 1984, 9, 365-370.
38. Sedvall, G.; Ehrin, E.; Farde, L. Human Psychopharmacol. 1987, 2, 23-30.
39. Wilson, A, A.; Dannals, R. F.; Ravert, H. T.; Gilbert, F. W.; Wong, D. F.; Wagner, H. N., Jr. J. Nucl. Med. 1987,28, Abstr. 718.
40. Farde, L.; Wiesel, F.-A.; Jansson, P.; Uppfeldt, G.; Wahlen, A.; Sedvall, G. Psychopharmacology 1988, 94, 1-7.
41. El Tayar, N.; van de Waterbeemd, H.; Testa, B. J. Chromatogr. 1985, 320, 293-304
42. El Tayar, N.; van de Waterbeemd, H.; Testa, B. J. Chromatogr. 1985, 320, 305-312.
43. De Vreis, D. J.; Beart, P. M. Mol. Brain Res. 1986, 1, 29-35.